Article: Research company is ordered to give teen experimental drug

NEWARK, N.J. -- A federal judge on Wednesday ordered a research company to supply an experimental drug to a 16-year-old Minnesota boy who is terminally ill with a rare form of muscular dystrophy.

The decision offers no immediate relief to Jacob Gunvalson. Due to federal regulations, the teen cannot begin taking the drug immediately.

PTC Therapeutics plans to appeal the ruling by U.S. District Judge William J. Martini, who also denied the company's request to put his decision on hold while it was appealed.

Jacob's family contends that PTC, of South Plainfield, led them to believe he could participate in a clinical trial of the drug, which is being investigated as a possible treatment. But ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!